Dolores Caballero
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 34
- Acute Myeloid Leukemia Research 13
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 70
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 28
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments 12
- Oncology top 1%
- Viral-associated cancers and disorders 22
- CAR-T cell therapy research 11
-
- Acute Lymphoblastic Leukemia research 12
- Co-authors
- Jesús F. San MiguelJosè Antonio Pérez-SimónLourdes VázquezRodrigo MartinoBertrand CoiffierMarcos GonzálezNorbert SchmitzSarah McCue Horwitz
- Partner nations
- SpainFranceUnited States
In The Last Decade
Dolores Caballero
132 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Hematology 1.7k
- Pathology and Forensic Medicine 2.0k
- Genetics 1.1k
- Transplantation 216
- Oncology 1.8k
Countries citing papers authored by Dolores Caballero
This map shows the geographic impact of Dolores Caballero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolores Caballero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolores Caballero more than expected).
Fields of papers citing papers by Dolores Caballero
This network shows the impact of papers produced by Dolores Caballero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolores Caballero. The network helps show where Dolores Caballero may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dolores Caballero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2020 | 20 | |
| 4 | 2018 | 16 | |
| 5 | 2017 | 11 | |
| 6 | 2017 | 15 | |
| 7 | 2016 | 8 | |
| 8 | 2015 | 12 | |
| 9 | 2015 | 34 | |
| 10 | 2013 | 77 | |
| 11 | Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapybreakdown → | 2012 | 485 |
| 12 | 2012 | 17 | |
| 13 | patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial | 2011 | 1 |
| 14 | 2011 | 2 | |
| 15 | 2011 | 16 | |
| 16 | 2009 | 8 | |
| 17 | 2009 | 70 | |
| 18 | 2009 | 24 | |
| 19 | 2005 | 60 | |
| 20 | 2004 | 40 |
About Dolores Caballero
Dolores Caballero is a scholar working on Transplantation, Hematology and Pathology and Forensic Medicine, having authored 137 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (70 papers), Hematopoietic Stem Cell Transplantation (34 papers), Chronic Lymphocytic Leukemia Research (28 papers), Viral-associated cancers and disorders (22 papers), Acute Myeloid Leukemia Research (13 papers), Renal Transplantation Outcomes and Treatments (12 papers), Acute Lymphoblastic Leukemia research (12 papers) and CAR-T cell therapy research (11 papers). The work is most often cited by research in Hematology (1.7k citations), Pathology and Forensic Medicine (2.0k citations) and Genetics (1.1k citations). Dolores Caballero has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Jesús F. San Miguel, Josè Antonio Pérez-Simón, Lourdes Vázquez, Rodrigo Martino, Bertrand Coiffier, Marcos González, Norbert Schmitz, Sarah McCue Horwitz, María Díez‐Campelo and Lubomir Sokol.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.